A Prospective Study on Antihypertensives Utilization in Type 2 Diabetic patients in a Tertiary Care Teaching Hospital

  • Tushar Vasudev Vyas Associate Prof., Department of Medicine, American International Institute of Medical Sciences, Udaipur
Keywords: Diabetes, Hypertension, Angiotensin receptor blocker

Abstract

Background: Hypertension is more prevalent in Type 2 Diabetes Mellitus patients. Hypertension is risk factor not only for development of diabetes but also for complications like nephropathy, CAD and neuropathy etc. Hypertension control is vital to prevent and retard progression of microvascular and macrovascular complications. Therefore, this study was carried out to evaluate treatment patterns in diabetic patients with hypertension, those are being followed at our institute.

Methods: This study was conducted on diabetic patients, who are also suffering from Hypertension. Prescribing Pattern of Antihypertensive drugs was analysed on all diabetic patients reporting to medicine OPD at Department of Medicine, AIIMS, Udaipur   and were screened. 

Results: Out of n=110 patients, 62 were males and 48 were females. Mean age of group was 47.65 years. 46.18% patients were on monotherapy and remaining patients were on combination antihypertensive drugs. There were total 260 antihypertensive drug exposures. Angiotensin receptor blockers were the most commonly prescribed drugs (n=48). Angiotensin inhibitors (angiotensin receptor blockers and ACE inhibitors) were utilized in majority of the patients. Hypertension control was achieved in 42.36% patients. About 78.58% were aware about the disease.

Conclusions: Our study revealed that majority of diabetic hypertensive patients were administered multiple drug therapy in order to control hypertension. Majority of the patients were on ARBs/ACE inhibitors. This was according to recommendation by ADA or JNC8.

Downloads

Download data is not yet available.

References

1. Sicree R, Shaw J, Zimmet P. Diabetes and impaired glucose tolerance. In: Gan D, eds. Diabetes Atlas. International Diabetes Federation. 3rd ed. Brussels, Belgium: International Diabetes Federation; 2006: 15-103.
2. National Institutes of Health. Diabetes in America. In: NIH, eds. National Institutes of Diabetes and Digestive and Kidney Diseases. 2nd ed. Bethesda, MD: NIH Publication; 1995: 95-1468.
3. Miller GJ, Maude GH, Beckles GLA. Incidence of hypertension and non-insulin dependent diabetes mellitus and associated risk factors in a rapidly developing Caribbean community: the St James survey, Trinidad. J Epidemiol Community Health. 1996;50(5):497-504.
4. UKPDS 38. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UK prospective diabetes study group. BMJ. 1998; 317(7160):703-13.
5. James PA, Oparil S, Carter BL, Cushman WC, Dennison HC, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth Joint National Committee (JNC 8). JAMA. 2014;311(17):1809.
6. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013 Jul;34(28):2159-219.
7. American Diabetes Association. Standards of medical care-2014. Diabetes Care. 2014 Jan;37(Suppl 1):S14-80.
8. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis. 2000;36(3):646-61.
9. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981-97
10. Berlowitz DR, Ash AS, Hickey EC, Glickman M, Friedman R, Kader B. Hypertension management in patients with diabetes: the need for more aggressive therapy. Diabetes Care. 2003;26(2):355-9.
11. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28(12):1462-536.
12. Nather A, Bee CS, Huak CY, Chew JL, Lin CB, Neo S, et al. Epidemiology of diabetic foot problems and predictive factors for limb loss. J Diabetes Complicat. 2008;22(2):77-82.
13. Reiber GE. The epidemiology of diabetic foot problems. Diabet Med. 1996;13(Suppl 1):S6-11.
14. Shah J, Khakhkhar T, Bhirud S, Shah RB, Date S. Study of utilization pattern of antihypertensive drugs in hypertensive diabetic patients with or without reduced renal function at tertiary care teaching hospital. Int J Med Sci Public Health. 2013;2:175-80.
15. Ashfaq T, Anjum Q, Siddiqui H, Shaikh S, Vohra EA. Awareness about hypertension among patients attending primary health care centre and outpatient department of tertiary care hospital of Karachi. J Pak Med Assoc. 2007;57(8):396-9.
Published
2019-12-24
How to Cite
1.
Vyas TV. A Prospective Study on Antihypertensives Utilization in Type 2 Diabetic patients in a Tertiary Care Teaching Hospital. Int Arch BioMed Clin Res [Internet]. 2019Dec.24 [cited 2020Feb.26];5(4):GM6-GM8. Available from: http://iabcr.org/index.php/iabcr/article/view/535
Section
ORIGINAL ARTICLES ~ General Medicine